Extended-release tolterodine is an effective and convenient option in the treatment of overactive bladder

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 2, 2005-02 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Oxybutynin Extended-Release: A Review of its Use in the Management of Overactive Bladder

By Siddiqui M.A.A.   Perry C.M.   Scott L.J.  

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 885-912

Adis International

Access to resources Recommend Favorite

Extended-Release Oxybutynin

By Comer A.M.   Goa K.L.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 149-155

Adis International

Access to resources Recommend Favorite

Transdermal Oxybutynin: For Overactive Bladder

By Bang L.M.   Easthope S.E.   Perry C.M.  

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 857-864

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

By Guest J.F.   Abegunde D.   Ruiz F.J.  

Clinical Drug Investigation, Vol. 24, Iss. 6, 2004-01 ,pp. : 305-321

Adis International

Access to resources Recommend Favorite